All articles published in Signal Transduction and Targeted Therapy are made freely and permanently available online immediately upon publication, without subscription charges or registration barriers.

As a leader in the global movement toward open access to publicly funded research, the University of California is taking a firm stand by deciding not to renew its subscriptions with Elsevier. Despite ...